Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1912 1
1923 1
1924 1
1928 2
1929 2
1930 2
1932 2
1933 2
1935 2
1936 1
1937 2
1938 1
1940 1
1943 1
1945 1
1946 12
1947 8
1948 9
1949 9
1950 7
1951 15
1952 8
1953 9
1954 12
1955 13
1956 9
1957 9
1958 17
1959 12
1960 14
1961 9
1962 20
1963 26
1964 16
1965 34
1966 27
1967 30
1968 37
1969 40
1970 43
1971 30
1972 29
1973 44
1974 42
1975 27
1976 58
1977 48
1978 65
1979 56
1980 68
1981 67
1982 68
1983 70
1984 73
1985 74
1986 84
1987 84
1988 102
1989 120
1990 111
1991 145
1992 147
1993 139
1994 159
1995 165
1996 163
1997 170
1998 166
1999 180
2000 193
2001 170
2002 217
2003 215
2004 253
2005 242
2006 304
2007 345
2008 357
2009 330
2010 412
2011 449
2012 506
2013 497
2014 560
2015 561
2016 557
2017 579
2018 592
2019 615
2020 739
2021 798
2022 719
2023 557

Text availability

Article attribute

Article type

Publication date

Search Results

12,750 results

Results by year

Filters applied: . Clear all
Page 1
International consensus statement on allergy and rhinology: Allergic rhinitis - 2023.
Wise SK, Damask C, Roland LT, Ebert C, Levy JM, Lin S, Luong A, Rodriguez K, Sedaghat AR, Toskala E, Villwock J, Abdullah B, Akdis C, Alt JA, Ansotegui IJ, Azar A, Baroody F, Benninger MS, Bernstein J, Brook C, Campbell R, Casale T, Chaaban M, Chew FT, Chambliss J, Cianferoni A, Custovic A, Davis EM, DelGaudio JM, Ellis AK, Flanagan C, Fokkens WJ, Franzese C, Greenhawt M, Gill A, Halderman A, Hohlfeld JM, Incorvaia C, Joe SA, Joshi S, Kuruvilla ME, Kim J, Klein AM, Krouse HJ, Kuan EC, Lang D, Larenas-Linnemann D, Laury AM, Lechner M, Lee SE, Lee VS, Loftus P, Marcus S, Marzouk H, Mattos J, McCoul E, Melen E, Mims JW, Mullol J, Nayak JV, Oppenheimer J, Orlandi RR, Phillips K, Platt M, Ramanathan M Jr, Raymond M, Rhee CS, Reitsma S, Ryan M, Sastre J, Schlosser RJ, Schuman TA, Shaker MS, Sheikh A, Smith KA, Soyka MB, Takashima M, Tang M, Tantilipikorn P, Taw MB, Tversky J, Tyler MA, Veling MC, Wallace D, Wang Y, White A, Zhang L. Wise SK, et al. Among authors: smith ka. Int Forum Allergy Rhinol. 2023 Apr;13(4):293-859. doi: 10.1002/alr.23090. Epub 2023 Mar 6. Int Forum Allergy Rhinol. 2023. PMID: 36878860 Free article. Review.
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. Among authors: smith kl. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Clinical Trial.
Persistent mutation burden drives sustained anti-tumor immune responses.
Niknafs N, Balan A, Cherry C, Hummelink K, Monkhorst K, Shao XM, Belcaid Z, Marrone KA, Murray J, Smith KN, Levy B, Feliciano J, Hann CL, Lam V, Pardoll DM, Karchin R, Seiwert TY, Brahmer JR, Forde PM, Velculescu VE, Anagnostou V. Niknafs N, et al. Among authors: smith kn. Nat Med. 2023 Feb;29(2):440-449. doi: 10.1038/s41591-022-02163-w. Epub 2023 Jan 26. Nat Med. 2023. PMID: 36702947 Free PMC article.
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer.
Rosner S, Reuss JE, Zahurak M, Zhang J, Zeng Z, Taube J, Anagnostou V, Smith KN, Riemer J, Illei PB, Broderick SR, Jones DR, Topalian SL, Pardoll DM, Brahmer JR, Chaft JE, Forde PM. Rosner S, et al. Among authors: smith kn. Clin Cancer Res. 2023 Feb 16;29(4):705-710. doi: 10.1158/1078-0432.CCR-22-2994. Clin Cancer Res. 2023. PMID: 36794455 Free PMC article.
In Science Journals.
Scanlon ST, Smith KT, Yeston J, Lavine MS, Lopez B, Malo C, VanHook AM, Uzogara E, Hurtley SM, Kelly PN, Grocholski B, Maroso M, Isles HM. Scanlon ST, et al. Among authors: smith kt. Science. 2023 Sep 8;381(6662):1061-1063. doi: 10.1126/science.adk6371. Epub 2023 Sep 7. Science. 2023. PMID: 37676937
In Science Journals.
Lopez B, Vignieri S, Osborne IS, Yeston J, Jiang D, Suleymanov Y, Grocholski B, Malo CS, Kelly PN, Scanlon ST, Ray LB, Smith KT, Ferrarelli LK, Smith HJ, Olingy C. Lopez B, et al. Among authors: smith kt. Science. 2023 Jun 9;380(6649):1024-1025. doi: 10.1126/science.adj0815. Epub 2023 Jun 8. Science. 2023. PMID: 37289882
In Science Journals.
Furlong K, Hurtley SM, Szuromi P, Jiang D, Smith KT, Hallberg DL, Ray LB, Olingy C, Lavine MS, Ferrarelli LK, Suleymanov Y. Furlong K, et al. Among authors: smith kt. Science. 2023 Apr 28;380(6643):373-375. doi: 10.1126/science.adi4115. Epub 2023 Apr 27. Science. 2023. PMID: 37104577
12,750 results
You have reached the last available page of results. Please see the User Guide for more information.